Ajanta Pharma's Q1 FY24 consolidated PAT up at Rs. 208.12 Cr
News

Ajanta Pharma's Q1 FY24 consolidated PAT up at Rs. 208.12 Cr

The company has reported total income of Rs. 1052.79 crores during the period ended June 30, 2023

  • By IPP Bureau | July 28, 2023

Ajanta Pharma Limited has reported Consolidated financial results for the period ended June 30, 2023.

Ajanta Pharma has posted net profit of Rs. 208.12 crores for the period ended June 30, 2023 as against net profit of Rs. 122.25 crores for the period ended March 31, 2023. It posted net profit of Rs.174.62 crores for the period ended June 30, 2022.

The company has reported total income of Rs. 1052.79 crores during the period ended June 30, 2023 as compared to Rs. 918.67 crores during the period ended March 31, 2023. It reported total income of Rs.983.69 crores during the period ended June 30, 2022.

Upcoming E-conference

Other Related stories

Startup

Digitization